Nicorama Mint (Nicotine Resinate)

Nicotine Resinate, the active ingredient in Nicorama Mint, is a nicotinic receptor agonist presented as an oral formulation for oral use. It helps adult smokers manage nicotine withdrawal symptoms during smoking cessation attempts.

GNH USA supplies Nicorama Mint as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Nicotine Resinate is used in nicotine replacement therapy to address nicotine dependence.

- Smoking cessation: reduces cravings and withdrawal symptoms to support quitting tobacco use. - Relapse prevention: helps maintain abstinence after initial quitting. - Tobacco use disorder: provides a controlled nicotine source to facilitate gradual reduction.

Adverse reactions may occur with any nicotine replacement product. Most are mild and transient.

Common Side Effects: - Mouth irritation or soreness - Nausea or mild stomach upset - Headache - Dizziness - Insomnia or sleep disturbances - Throat irritation

Serious or Rare Side Effects: - Allergic reaction (rash, swelling, difficulty breathing) - Chest pain or palpitations - Rapid heart rate (tachycardia) - Severe nausea or vomiting - Low blood pressure (hypotension) - Seizures (very rare)

Before using Nicorama Mint, consider the following safety measures.

- Assess nicotine dependence: determine appropriate use based on smoking history. - Avoid use in non‑smokers or former smokers who are nicotine‑free. - Monitor cardiovascular status: patients with heart disease should use under medical guidance. - Do not combine with other nicotine replacement products without professional advice. - Keep out of reach of children and pets. - Store at ambient temperature: keep in the original pack, protect from moisture and direct sunlight.

Nicorama Mint may interact with other substances that affect nicotine metabolism or cardiovascular function.

Major Interactions (Avoid): - Concurrent use of other nicotine replacement therapies (gum, patch, inhaler). - Monoamine oxidase inhibitors (may increase nicotine effects).

Moderate Interactions (Monitor Closely): - Beta‑blockers or other antihypertensive agents (potential additive heart rate effects). - Certain antidepressants (e.g., bupropion) that influence nicotine pathways. - Caffeine‑containing products (may enhance stimulant effects).